Neurotrophins (NTs) are the major contributors of sensory axonal sprouting, neural survival, regulation of nociceptive sensory neurons, inflammatory hyperalgesia, and neuropathic pain.
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Neurotrophins (NTs) are the major contributors of sensory axonal sprouting, neural survival, regulation of nociceptive sensory neurons, inflammatory hyperalgesia, and neuropathic pain.
Intervertebral disc (IVD) cells constitutively express NTs. Their expression is upregulated by proinflammatory cytokines present in the IVD during degeneration, which can promote peripheral nerve ingrowth and hyperinnervation, leading to discogenic pain. Currently, there are no targeted therapies that decrease hyperinnervation in degenerative disc disease. Link N is a naturally occurring peptide with a high regenerative potential in the IVD. Therefore, the suitability of Link N as a therapeutic peptide for suppressing NTs, which are known modulators and mediators of pain, was investigated. The aim of the present study is to determine the effect of Link N on NTs expression, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and their cognate receptors TrkA and TrkB as they are directly correlated with symptomatic back pain. Furthermore, the neurotransmitter (substance P) was also evaluated in human annu- Thus, coupled with previous observations, this suggests that administration of Link N has the potential to not only repair the discs in early stages of the disease but also suppress pain.
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| INTRODUCTION
The intervertebral discs (IVDs) are the main joints between two adjacent vertebrae within the spine. They are composed of the annulus fibrosus (AF), the central gelatinous nucleus pulposus (NP), and two endplates of hyaline cartilage that sandwich the AF and NP. 1 In the adult human, the chondrocyte-like NP cells are responsible for maintaining an extracellular matrix composed of randomly organized collagen fibrils and a high content of aggrecan. 2 The fibroblast-like AF cells are arranged parallel to the collagen fibers.
Aging, poor nutrition, biomechanical, [3] [4] [5] [6] biochemical, [7] [8] [9] [10] [11] and genetic factors [12] [13] [14] [15] are related to increased IVD degeneration.
During degeneration, loss of proteoglycan content in the NP occurs, changing it from a gelatinous structure to a fibrotic texture as it becomes more collagenous, and fissures appear in both the NP and AF. 16, 17 In normal human and animal IVDs, only the periphery of the AF is innervated by sensory and sympathetic perivascular nerve fibers. 18, 19 It has been observed that the degenerative discs causing low back pain contain higher concentrations of sensory nerves in the endplates and NP compared with the painless degenerative IVDs. 20, 21 This suggests that degeneration is commonly associated with back pain of IVD origin, possibly due to the increase in the number of nerve fibers in the IVD and loss of disc height. 22 However, the mechanisms responsible for increased innervation of the IVD are unclear.
Currently, IVD hyperinnervation is often envisaged in terms of growth factors that are members of the NT family [23] [24] [25] and "neurogenic" factors released by degenerative IVDs. 26, 27 The density and distribution of sensory and sympathetic nerve fibers in peripheral tissues are dependent upon NTs for them to be able to survive through mechanisms that are not known, and the presence of growth factors will determine how many neurons will survive and the density of innervation. 28 These molecules and their receptors have been observed locally in degenerative discs and from patients suffering from discogenic pain. 29, 30 Among the family of NTs are nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), which exert their effects through a family of tyrosine kinase (Trk) receptors TrkA and TrkB, respectively. 31 Disc cells are thought to be both a source and a target for NTs. 31 Overexpression of NTs in the skin can lead to enhanced innervation and numbers of neurons in sensory ganglia. 32 Conversely, in null mutants of NTs and their cognate receptors, most of the neurons are lost in the trigeminal ganglion, the primary sensory ganglion innervating the skin of the face and oral cavity. 33 In the disc, hyperinnervation and NTs appear to play a key role in generating pain in the degenerative IVDs. The mechanisms by which neurons become reliant on NTs are not known. However, it has been shown that members of the bone morphogenetic protein (BMP) family can limit the population of neurons.
Although the AF is the main target of innervation of the discs, there are no targeted therapies that decrease hyperinnervation in degenerative disc disease. Link N is a 16-amino acid, naturally occurring peptide, which represents the N-terminal region of the link protein that stabilizes proteoglycan aggregates in both disc and cartilage, and is generated by MMPs during tissue turnover in vivo. We and others have previously shown the regenerative potential in the IVD. [34] [35] [36] [37] Link N acts through the BMP type II receptor. Receptor activation leads to Smad1/5 signaling and an upregulation of BMP-4
and BMP-7 message levels. 38 The purpose of this study was to investigate the effects of 
| Immunohistochemistry and staining
The AF tissue from human IVDs with degenerative grades 2 to 
| NGF protein expression in IVDs with different degenerative grades
The AF tissues from human IVDs with degenerative grades 2 to and TNF 100 ng/mL with Link N 1 μg/mL was normalized to IL-1β 10 ng/mL and TNF 100 ng/mL incubation, respectively.
| Statistical analysis
Data were analyzed by Analysis of Variance (ANOVA) followed by a post hoc Dunnett's test. A P-value of less than .05 was considered statistically significant.
| RESULTS
NGF is known to be a major contributor of sensory axonal sprouting, neural survival, regulation of nociceptive sensory neurons, inflammatory hyperalgesia, and neuropathic pain. 29, 30, 39 To determine the expression of NGF with grade of degeneration in human AF cells, we NGF can be upregulated by proinflammatory cytokines which are present in disc degeneration in vivo. [40] [41] [42] To determine the effect of The neurotrophic factors and/or neurotransmitters can also be upregulated by TNF-α. 41 To investigate this, human AF cells were NGF is known to be a major contributor to sprouting of sensory axons, neural survival, regulation of nociceptive sensory neurons, inflammatory hyperalgesia, and neuropathic pain. The question whether NGF is expressed in different parts of normal IVD and its relationship to disc degeneration has been widely discussed. 29, 30, 39 It is thought that enhanced expression of NGF is then transported to the dorsal root ganglion where it acts on TrkA-expressing neurons. We and others have previously demonstrated that Link N can act as an anabolic agent in the disc enhancing proteoglycan synthesis and depleting proteinase expression. [34] [35] [36] [37] [38] 44, 45, 48, [52] [53] [54] [55] [56] [57] [58] [59] [60] We have
shown that Link N can maintain its anabolic effects in an inflammatory milieu when human IVD cells were exposed to IL-1. and the receptor for SP, TAC1R, nociceptive factors shown to be upregulated by inflammatory cytokines in IVD cells. 47 The inflammatory cytokine, TNF-α, has also been purported to upregulate factors associated with discogenic pain in IVD cells. 46 Our data indicate that Link N can inhibit the upregulation of NTs and their receptors in human AF cells following TNF-α exposure.
Recently, it has been demonstrated that Link N can stimulate the BMP type II receptor activating Smad1/5 signaling and upregulating BMP4 in IVD cells. 38, 48 BMP4 has been demonstrated to decrease peripheral innervation in an animal model. 49 Therefore, one mechanism for the ability of Link N to inhibit the expression of NTs associated with pain in the IVD is by activating the BMP signaling pathway.
Another mechanism by which Link N may be inhibiting the induction of NTs by inflammatory cytokines in IVD cells is by decreasing cytokine signaling pathway. In our unpublished work, human chondrocytes coexposed to IL-1β and Link N demonstrated a reduced activation of nuclear factor-κB when compared to chondrocytes treated with IL-1β alone. 50 Since the IL-1β signaling pathway is important in mediating NTs upregulation, factors that inhibit IL-1β receptor signaling (ie, IL-1 receptor antagonist) may play a role in regulating the pathogenesis of degenerative IVD disease. post hoc Dunnetts's; *P < .05; **P < .01; ****P < .0001) ). This suggests that Link N would have no effect on nociceptive nerve ingrowth into the disc IVD and associated pain.
Recently, we modeled discogenic pain in a slowly progressive surgical mouse model of discogenic low back pain, induced by stabbing the lumbar discs (L4/5, L5/6, and L6/S1) and removing a part of the NP 51 and monitor pain-related behaviors longitudinally over 12 weeks. Future studies will determine the effect of Link N on pain in this mouse model by either administering Link N prophylactically starting at time of surgery for 8 weeks or whether the disease can be modulated when targeted therapeutically. These studies will help to address some key questions as to (1) whether affecting disc pathology will modulate plasticity changes in the pain pathway and (2) whether there are optimal times during the disease process to achieve this effect.
In Table 1 , we show that Link N is an ideal IVD target profile based on the present study and other published work. [35] [36] [37] 45, [52] [53] [54] [55] [56] [57] [58] [59] [60] In Table 2 , a summary of the clinical and market opportunities for Link N is presented.
The fact that NGF positivity was highest in Thompson grade IV discs raises the question of whether Link N would work to relieve pain in patients with early stage degenerative disc disease, considering that NGF expression might be significantly lower compared to
Thompson grade IV or V. We have no reason to believe that it would not work as in earlier work with painful IVD excised from patients with back pain, it was found that only painful IVD expressed NGF produced by microvessels which come to populate the normally avascular IVD. 29 In the present study, although the levels of NGF FIGURE 6 Effect of Link N on tumor necrosis factor-α (TNF-α)-induced nerve growth factor (NGF), BDNF gene expression. Changes in NGF, TrkA, brain-derived neurotrophic factor (BDNF), and TrkB gene expression in normal human annulus fibrosus (AF) cells after 48 hours exposure to Link N (1 μg/mL) + TNF-α (100 ng/mL) or TNF-α (100 ng/mL) alone. The results are shown as means AE SE (n = 3; ANOVA, post hoc Dunnetts's; *P < .05; **P < .01; ***P < .001) FIGURE 7 Effect of Link N on tumor necrosis factor-α (TNF-α)-induced substance P (SP) gene expression. Changes in TAC1 and TAC1R gene expression in normal human annulus fibrosus (AF) cells after 48 hours exposure to Link N (1 μg/mL) + TNF-α (100 ng/mL) or TNF-α (100 ng/mL) alone supplementation. The results are shown as means AE SE (n = 3; ANOVA, post hoc Dunnetts's; *P < .05; ***P < .001) expression were lower than those produced by grade IV discs, NGF blockade would be highly efficacious as recent clinical trials for knee osteoarthritis pain indicated. 61 Intradiscal injection (using a small gauge needle) would be a favored method for delivering Link N to get desired effects quickly and directly. Based on our previous studies and since the disc has no blood vessels, Link N would likely be diffused very slowly at a sustained rate.
In this study, we chose to examine the effects of Link N on proinflammatory-mediated regulation of NTs in the AF only because these cells were readily available and we were not sure if Link would have an effect or not. However, NP cells are also known to express the NTs NGF and BDNF. Thus, future studies will look at NP cells to see whether the same effects could be observed. The mechanisms by which Link N inhibits proinflammatory-mediated upregulation of NTs and SP are unclear. Link N acts through the BMP receptor and augments the effects of endogenous BMPs. 38 It is therefore possible that inhibition of proinflammatory-mediated upregulation of NTs and SP occurs indirectly because of BMPmediated changes in the disc.
In summary, our study demonstrates that Link N has the ability to suppress the NTs, NGF, and BDNF, as well as their receptors TrkA and TrkB. Link N was also able to suppress SP and its receptor TAC1R. These are features needed for any agent designed to suppress pain factors. Therefore, in principle, Link N supplementation could be a viable option for treating discogenic pain. Our results support the concept that the administration of Link N has therapeutic potential for pain relief. Performed at advanced levels of disc degeneration
Often leads to further degeneration in adjacent discs by altering biomechanics/kinematics
Prophylaxis to avoid surgery
In conjunction with/replacement for steroid injections Known short-term benefits of steroids, but long-term effectiveness was less established Steroids may address acute inflammation and allow the body's normal healing process to lead to long-term improvement, but do not cause disc repair
